Sponsored by
xCures is the company we use to run our registry and helps with our patient navigation program and they ran our Onc-201 expanded access program. (As a disclaimer, I am a consultant to xCures and own some xCures stock). They are now running a few other expanded access programs, including one for brain tumors with KRAS, NRAS, HRAS, BRAF, MEK, and ERK mutations. This announcement is about a new portal for doctors only where they can easily register patients for these expanded access programs. We have found that many doctors do not have the time to help a patient access a treatment via expanded access. This portal will make it a lot easier for them to do it, and make it much faster for them and you. They can also submit the required follow up information quickly in minutes. This is a big advance for doctors and removes a barrier to expanded access.